# Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin

> **NCT01312831** · NA · COMPLETED · sponsor: **Emisphere Technologies, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Vitamin B 12 Deficiency

## Interventions

- **OTHER:** Vitamin B12 (cyanocobalamin)

## Key facts

- **NCT ID:** NCT01312831
- **Lead sponsor:** Emisphere Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** —
- **Final completion:** 2010-12
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01312831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01312831, "Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01312831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*